Abstract submissions will be accepted from Wednesday, Sept. 4, 2024, at 9 a.m. EDT through Wednesday, Oct. 16, 2024, at 9 p.m. EDT. 

Changes to abstracts and author strings are not allowed after the October 16 submission deadline. Authors can edit their abstracts any time before this date, but any modifications must be made and saved by 9 p.m. EDT on October 16 to be considered for the meeting. No updates to abstracts or author lists will be accepted after this deadline. 

Authors can add co-authors to an existing abstract by logging into the Congress abstract submission site before the Oct. 16 deadline. No changes to author details will be accepted after this deadline. 

Yes. Authors must submit their financial disclosure at the abstract submission site. 

Author disclosures must be completed prior to abstract submission, so please plan ahead. The submission site will not permit submission of abstracts missing disclosures. 

Submitting authors will be able to send an email to co-authors from the submission site that contains a direct link to their disclosure forms. The message will also include the option to edit their profile and view a proof of the abstract. 

To send the message, submitters should click the blue “Invite” button next to an author’s name as listed on the Financial Disclosure task. 

All co-author disclosures are due at the abstract submission site by 9 p.m. EST on Wednesday, Oct. 16, 2024. Please note that disclosures must be completed prior to abstract submission. Abstracts missing any co-author disclosures cannot be submitted. 

In keeping with ACCME’s Standards for Integrity and Independence, the Congress requires that all individuals in a position to control the educational content of any accredited CE activity disclose all financial relationships with any ineligible company that they have had over the past 24 months. 

Specifically, all abstract authors are required to list the names of the ineligible companies with which they have relationships and also the roles they played within the named entities (e.g., employee, researcher, shareholder, executive, etc.) over the past 24 months. 

Authors without relationships may state that they have no information to disclose. 

• At any time, submitters can check the status of their co-authors’ disclosures by logging into the abstract submission site and selecting the Financial Disclosure task. 

If needed, submitting authors also have the option to complete and submit disclosure forms on behalf of their co-authors. By doing so, the submitter agrees to complete the forms to the best of their ability and accepts responsibility for the accuracy of the disclosures. 

The co-author may have multiple accounts. Contact the Congress Program Team with the co-author’s full name and email address of the co-author. If you’re certain of a duplicate account, include that account’s email address too.  

Submitting authors can send an email to co-authors from the submission site that contains a direct link to their disclosure forms. The message will also include the option to edit their profile and view a proof of the abstract. 

To send the message, submitters should click the blue “Invite” button next to an author’s name as listed on the Financial Disclosure task. 

If needed, submitting authors also have the option to complete and submit disclosure forms on behalf of their co-authors. By doing so, the submitter agrees to complete the forms to the best of their ability and accepts responsibility for the accuracy of the disclosures.   

Access your account at the Congress abstract submission site. 

Abstracts accepted for presentation at the 2025 Crohn’s & Colitis Congress will be published in February 2025 online supplements to Gastroenterology and Inflammatory Bowel Diseases. Accepted abstracts will also be published in the Congress Mobile App.  

All data presented at Congress is embargoed until 8 a.m. PST on the first day of the Congress. For more information, please refer to the Congress media policies.   

Abstracts will be made available online to attendees in advance of Congress for itinerary planning purposes. The embargo policy applies to all abstract data regardless of the date of publication in Congress resources.  

To increase the visibility and reach of your science, poster presenters are encouraged to submit an ePoster that will be made available in the Congress mobile app in addition to your physical poster display in the Poster Hall.  

Full instructions on creating and uploading an ePoster file will follow to accepted poster presenters by email in January. 

No. All abstract presentations will take place in person at the Moscone Center, West Building, Level 1 in San Francisco. Virtual presentations (e.g., pre-recorded videos and livestreams) will not be permitted.  

No edits to abstracts or author strings will be accepted after the Wednesday, Oct. 16, 2024, abstract submission deadline.   

Abstract authors retain the rights to their abstracts. However, other meetings may have rules regarding prior presentation and/or publication, so please contact meeting organizers for their specific policies.   

To withdraw your abstract, please contact the Congress Program Team.  Requests must be made by December 13, 2024. After this date, Congress cannot guarantee that a withdrawn abstract will be excluded from publication.    

Congress will send abstract notifications to presenting authors on December 9, 2024. The presentation type will be noted in this email.  

Abstract notifications will be sent to presenting authors on December 9, 2024. If you aren’t listed as the presenter, you will not receive a message.    

Email the Congress Program Team the co-author’s full name, abstract number, and both the incorrect and correct email addresses.  

Any author listed on an abstract author string may present an abstract. If you need to update the presenter for your abstract, please contact info@crohnscolitiscongress.org with your submission ID number and the name of the new presenter.  

All abstract presenters are required to register for Congress. Please review your invitation for specific information regarding registration details. 

Presenter guidelines will be published on the Congress website in December. 

Congress poster board size is 4’ (height) by 6’ (width).   

Poster presenters should remove their posters by 10:30 a.m. PST on Saturday, Feb. 8, 2025. Posters or other materials left in the Poster Hall after 10:30 a.m. will be discarded.     

Poster presenters are encouraged to submit a PDF ePoster that will be made available in the Congress mobile app in addition to your physical poster display in the Poster Hall.  

Full instructions on creating and uploading an ePoster file will follow to accepted poster presenters by email in January.  

The “no photos icon” will be distributed to all presenters in their invitations to present at the Congress. 

The Poster Hall reception will take place Friday, February 7, 2025, from 5 to 6:30 p.m. in Moscone West, Level 1, Exhibit Hall and Poster Hall.